Sleep

The US Food and Drug Administration (FDA) has created a new Digital Health Advisory Committee to help the agency explore...

Sen. Richard Blumenthal, D-Conn., has expanded his call to take action against medical device powerhouse Philips Respironics, sending a letter...

A new consensus survey confirms that human circadian clocks are highly sensitive to blue wavelengths—found in most of the lights...

Latinx kids who experienced depression, anxiety, or other mental health issues in middle school had a greater chance of developing...

New research reveals that Sleepio, a digital cognitive behavioral therapeutic for insomnia by Big Health, reduces anxiety symptoms in individuals...

Apnimed unveiled the full results of its MARIPOSA phase 2b trial, revealing that AD109, an investigational oral drug for obstructive...

US Senator Dick Durbin (D-IL), who recently addressed concerns about the high-profile Philips Respironics’ CPAP and ventilator recall in a...

Doctors believe they have uncovered reliable evidence to confirm the belief that taking benzodiazepines such as Valium and Ativan intermittently...

Alkermes plc will present new data related to ALKS 2680, the company’s novel, investigational orexin-2 receptor (OX2R) agonist in development...

By Philippa Martyr, The University of Western Australia This article is the first in The Conversation’s six-part series on insomnia,...